
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Nautilus Biotechnology
Nautilus Biotechnology, Inc. operates as a life sciences company. The Company develops a proteomics platform to enable fundamental advancements across biomedical research and drug discovery. Nautilus Biotechnology focuses on patients and healthcare professionals worldwide.
Stock Analysis

last close
$2.68
1-mo return
-24.4%
3-mo return
-34.8%
avg daily vol.
668.51T
52-week high
12.38
52-week low
2.55
market cap.
$376M
forward pe
-
annual div.
-
roe
-36.9%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
45.6%